Stock listing
NASDAQ:ALXN Alexion Pharmaceuticals Inc Stock
Follow Alexion Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ALXN
$182.50 USD
Close on Jul 21, 2021 · No longer trades
- Lowest – highest close
- $44.61 – $207.84 USDSince May 23, 2011 · lowest Jun 17, 2011 · highest Jul 23, 2015
Delisted NASDAQ:ALXN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ALXN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Alexion Pharmaceuticals Inc on 6ix
- Calls
- 3 calls with a replay · 3 with a transcript · latest Oct 29, 2020
- Decks
- 6 decks · latest Feb 11, 2021
Events
| Call | When | Status |
|---|---|---|
| Alexion Pharmaceuticals (0QZM) Q3 2020 Earnings Call | Thu, Oct 29, 2020 · 8:00 AM ET | Replay |
| Alexion Pharmaceuticals (0QZM) Q2 2020 Earnings Call | Thu, Jul 30, 2020 · 8:00 AM ET | Replay |
| Alexion Pharmaceuticals (0QZM) Q1 2020 Earnings Call | Wed, May 06, 2020 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2020 Earnings Presentation | Earnings | 19 slides | Feb 11, 2021 |
| 39th Annual J.P. Morgan Healthcare Conference (January 2021) | Conference | 35 slides | Jan 12, 2021 |
| Merger or Acquisition (December 2020) | Merger or acquisition | 26 slides | Dec 14, 2020 |
| 38th Annual J.P. Morgan Healthcare Conference (January 2020) | Conference | 35 slides | Jan 13, 2020 |
| Merger or Acquisition (October 2019) | Merger or acquisition | 19 slides | Oct 21, 2019 |
| Merger or Acquisition (October 2019) | Merger or acquisition | 21 slides | Oct 16, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Felix Baker Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Feb 8, 2010 – Jun 19, 2012 · Past); Synageva BioPharma Corp (Director · Aug 14, 2007 – Jun 22, 2015 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Seagen Inc (Director · May 25, 2007 – Dec 14, 2023 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past) | Director · Jun 22, 2015 – May 14, 2020 · Past |
| Julian Baker Other companies: Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Director · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Managing Partner, Baker Brothers Investments | Chairman, Incyte · Since at least Apr 25, 2006); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Apr 6, 2010 – Jun 19, 2012 · Past); Seagen Inc (Director · Jun 9, 2006 – Dec 14, 2023 · Past); Innoviva, Inc. (Director · Apr 26, 2006 – Apr 26, 2006 · Past); Genomic Health Inc (Director · Apr 25, 2006 – Oct 1, 2019 · Past); Synageva BioPharma Corp (Director · Apr 25, 2006 – Jun 22, 2015 · Past); Neurogen Corp (Director · Mar 15, 2006 – Dec 15, 2009 · Past) | Director · Jun 22, 2015 – May 14, 2020 · Past |
| David J Anderson Other companies: Corteva, Inc. (EVP, Chief Financial Officer · Apr 12, 2021 – Apr 12, 2024 · Past); Criteo SA (Interim CFO · May 18, 2020 – May 18, 2020 · Past); Nielsen Holdings PLC (CFO/COO · Sep 10, 2018 – Dec 5, 2019 · Past); Fifth Street Asset Management Inc (Director · Oct 29, 2014 – Jun 4, 2015 · Past); B/E Aerospace Inc (Director · Jun 10, 2014 – Apr 13, 2017 · Past); Cardinal Health, Inc. (Director · Apr 25, 2014 – Jan 16, 2018 · Past); American Electric Power Company, Inc. (Director · Apr 26, 2011 – Mar 31, 2022 · Past); Honeywell International Inc. (Sr. VP & CFO · Jan 6, 2006 – Apr 4, 2014 · Past) | EVP, Chief Financial Officer · Dec 12, 2016 – Dec 12, 2016 · Past |
| François Nader Other companies: Tectonic Therapeutic, Inc. (Chair, Board of Directors · Since at least Feb 23, 2026); Moderna, Inc. (Director · Since at least Dec 10, 2019); Tourmaline Bio Inc. (Director · May 6, 2021 – Jun 13, 2023 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Baxalta Inc (Director · Jul 27, 2015 – Jun 3, 2016 · Past); Acceleron Pharma Inc (Director · Dec 11, 2014 – Nov 19, 2021 · Past); Trevena, Inc. (Director · Jan 30, 2014 – May 20, 2015 · Past); NPS Pharmaceuticals Inc (President, CEO and Director, Director · Apr 8, 2013 – Feb 21, 2015 · Past) | Director · Nov 15, 2017 – Jul 21, 2021 · Past |
| Judith A. Reinsdorf Other companies: Toll Brothers, Inc. (Member of the Governance Committee · Since at least Dec 13, 2023); Nurix Therapeutics, Inc. (Director · Since at least Oct 1, 2021); Enpro Inc. (Director · Since at least Sep 1, 2021); Cornerstone Building Brands Inc (Director · Aug 19, 2021 – Jul 25, 2022 · Past); Dun & Bradstreet Holdings Inc. (Director · Jun 12, 2013 – Feb 8, 2019 · Past); Johnson Controls International plc (Executive VP & General Counsel · Mar 12, 2007 – Oct 12, 2017 · Past) | Director · Feb 5, 2018 – Jul 21, 2021 · Past |
| Martin Mackay Other companies: Kailera Therapeutics, Inc. (Co-Founder and Chair of Board, Rallybio Corporation · Since at least Apr 16, 2026); SpringWorks Therapeutics Inc (Director · Since at least Jul 29, 2024); Rallybio Corporation (Co-Founder and Chairman · Since at least Jul 28, 2021); Charles River Laboratories International, Inc. (Director · Since at least Jul 1, 2017); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Pfizer, Inc. (Senior Vice President · Sep 30, 2008 – May 14, 2010 · Past) | EVP & Global Head of R&D · May 13, 2013 – Feb 27, 2017 · Past |
| R Douglas Norby Other companies: Krystal Biotech, Inc. (Director · Sep 19, 2017 – May 31, 2018 · Past); Invensense Inc. (Director · Nov 15, 2011 – Sep 15, 2013 · Past); Magnachip Semiconductor Corporation (Director · Mar 10, 2011 – Mar 11, 2016 · Past); Ikanos Communications Inc (Director · Jan 5, 2011 – Oct 31, 2012 · Past); Intellon Corp (Director · Dec 12, 2007 – Dec 15, 2009 · Past); Tessera Technologies Inc (Officer · Jan 10, 2006 – Feb 23, 2006 · Past) | Director · Jan 9, 2006 – May 10, 2017 · Past |
| Brian Goff Other companies: Intellia Therapeutics, Inc. (Independent Director · Since at least Jun 13, 2024); Agios Pharmaceuticals, Inc. (Chief Executive Officer · Since at least Aug 8, 2022); Baxalta Inc (EVP and President, Hematology · Jun 30, 2015 – Jun 3, 2016 · Past); Idenix Pharmaceuticals Inc (Director · Mar 27, 2012 – Mar 27, 2012 · Past) | EVP & Chief Commercial Officer · Jun 1, 2017 – Jul 21, 2021 · Past |
| John Moriarty Other companies: Kardigan, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Jun 17, 2026); Avidity Biosciences, Inc (Chief Legal Officer · Since at least Aug 1, 2024); Olema Pharmaceuticals, Inc. (EVP, Ch. Legal Officer & Sec. · Sep 19, 2020 – Feb 1, 2023 · Past); Portola Pharmaceuticals Inc (EVP, General Counsel · Mar 12, 2018 – Jul 2, 2020 · Past) | EVP & General Counsel · Dec 10, 2012 – Feb 6, 2018 · Past |
| Vikas Sinha Other companies: Scholar Rock Holding Corporation (Chief Financial Officer · Since at least Apr 27, 2025); Verona Pharma plc (Director · Since at least Jan 1, 2021); BCLS Acquisition Corp (Director · Oct 22, 2020 – Oct 22, 2020 · Past); Kalaris Therapeutics, Inc. (See Remarks, Director · Jul 29, 2020 – Feb 21, 2025 · Past) | EVP & CFO · Jul 12, 2013 – Aug 8, 2016 · Past |
All 25 people
| Person | Seat |
|---|---|
| Christopher J Coughlin Other companies: Centene Corporation (Director · Since at least Jan 5, 2022); Prestige Consumer Healthcare Inc. (Director · Aug 3, 2021 – Aug 2, 2022 · Past); Karuna Therapeutics Inc (Director · Jun 16, 2021 – Mar 18, 2024 · Past) | Director · May 20, 2021 – Jul 21, 2021 · Past |
| Indrani Lall Franchini Other companies: Avanos Medical, Inc. (Director · Since at least Jul 1, 2024); Alnylam Pharmaceuticals, Inc. (EVP, CLO & Secretary · Jan 31, 2022 – Feb 27, 2024 · Past) | EVP, Chief Compliance Officer · Feb 6, 2018 – Jul 21, 2021 · Past |
| Ludwig Hantson Other companies: Ionis Pharmaceuticals, Inc. (Director · Since at least Jun 4, 2026); Hologic Inc (Director · Since at least Mar 11, 2021) | CEO, Director · Dec 16, 2020 – Jul 21, 2021 · Past |
| Edward Miller Other companies: Kalaris Therapeutics, Inc. (General Counsel · Jul 29, 2020 – Feb 21, 2025 · Past) | SVP, Chief Compliance Officer · Sep 9, 2016 – Feb 27, 2017 · Past |
| Larry Mathis Other companies: Healthcare Realty Trust Incorporated (Director · Dec 8, 2010 – Jul 9, 2019 · Past) | Director · May 12, 2010 – Feb 28, 2014 · Past |
| Ruedi E Waeger Other companies: Talecris Biotherapeutics Holdings Corp (Director · Sep 30, 2009 – Jun 1, 2011 · Past) | Director · Jan 9, 2006 – May 3, 2010 · Past |
| Tanisha Carino Other companies: Silk Road Medical Inc (Director · Jul 22, 2021 – Sep 17, 2024 · Past) | EVP & CCAO · Nov 4, 2019 – Jul 21, 2021 · Past |
| Thomas Dubin Other companies: Intensity Therapeutics, Inc. (Board Member · Since at least May 14, 2024) | SVP & Chief Legal Officer · Jul 11, 2007 – Aug 23, 2012 · Past |
| Andreas Rummelt | Director · Feb 23, 2010 – Jul 21, 2021 · Past |
| Christopher F Mojcik | SVP Clinical Development · Jan 9, 2006 – May 29, 2007 · Past |
| Clare Carmichael | EVP, Chief HR Officer · Aug 29, 2011 – Feb 27, 2017 · Past |
| Daniel Bazarko | SVP, Controller, CAO · Feb 14, 2019 – Jul 21, 2021 · Past |
| Joseph A Madri | Director · Jan 9, 2006 – Mar 11, 2014 · Past |
| Leonard Bell | Director · May 11, 2016 – Feb 28, 2017 · Past |
| William R Keller | Director · May 12, 2010 – Dec 4, 2014 · Past |
Log in to ask 6ix AI your own questions about Alexion Pharmaceuticals Inc.